Citius Oncology Inc

TENKU's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

TENKU Growth rates comparisons

Citius Oncology Inc's sales fell in the third quarter of 2025 from the same quarter a year ago.

Major Pharmaceutical Preparations industry recorded growth of revenues by 8.14 %

Citius Oncology Inc faced net loss in contrast to the net income a year ago in third quarter of 2025

• More on TENKU's Growth

TENKU's Valuation comparisons

Citius Oncology Inc
realized a net loss in trailing twelve months.

Citius Oncology Inc realized cash reduction of $ -0 per share in trailing twelve-month period.

Company

PE TTM

Industry

PE TTM

Major Pharmaceutical Preparations industry's Price to Sales ratio is at 6.17.

• More on TENKU's Valuation

Total Debt (Millions $)	4
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Revenue/Employee (TTM) $	-
Net Income/Employee (TTM) $	-
Receivable Turnover (TTM)	-
Tangible Book Value (Per Share $)	0.45

TENKU's Valuation comparisons

Citius Oncology Inc
realized net loss in trailing twelve months.

Citius Oncology Inc realized cash outflow of $ -0per share in trailing twelve-month period.

Company

PE TTM

Industry

PE TTM

Major Pharmaceutical Preparations industry's Price to Sales ratio is at 6.17.

Citius Oncology Inc Price to Book Ratio is at 97.18 lower than Industry Avg. of 110.55. and higher than S&P 500 Avg. of 0.02

• More on TENKU's Valuation

• Market Capitalization (Millions $)	3,148
• Shares Outstanding (Millions)	72
• Employees	-
• Revenues (TTM) (Millions $)	-
• Net Income (TTM) (Millions $)	-12
• Cash Flow (TTM) (Millions $)	-
• Capital Exp. (TTM) (Millions $)	-
• Total Debt (Millions $)	4
• Dividend TTM ($)	0 $
• Dividend Yield TTM (%)	-
• Revenue/Employee (TTM) $	-
• Net Income/Employee(TTM) $	-
• Receivable Turnover Ratio (TTM)	-
• Tangible Book Value (Per Share $)	0.45

• Market Capitalization (Millions $)	3,148
• Shares Outstanding (Millions)	72
• Employees	-
• Revenues (TTM) (Millions $)	-
• Net Income (TTM) (Millions $)	-12
• Cash Flow (TTM) (Millions $)	-
• Capital Exp. (TTM) (Millions $)	-

	*Ratio*
• Capital Ratio (MRQ)	0.35
• Total Debt to Equity (MRQ)	0.12
• Tangible Leverage Ratio (MRQ)	1.83
• Asset Turnover Ratio (TTM)	-
• Inventory Turnover Ratio (TTM)	-

TENKU's Profitability Comparisons

• More on TENKU's Key Ratios

Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.